Causes of death in pediatric systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 27, Issue 3, 2009, Pages 538-539

  Klein, A ^a   Cimaz, R ^b   Quartier, P ^c   Decramer, S ^d   Niaudet, P ^c   Baudouin, V ^e   Belot, A ^b   Bader Meunier, Brigitte ^c  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d CHU PURPAN   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HEPARIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; EPILEPTIC STATE; FATALITY; FEMALE; HEART INFARCTION; HISTOPLASMOSIS; HUMAN; INFECTION; KIDNEY FAILURE; LETTER; LUNG EMBOLISM; LUNG HEMORRHAGE; MALE; PANCREATITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADOLESCENT; BACTERIAL INFECTIONS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS; FEMALE; FRANCE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PANCREATITIS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES;

EID: 67651154538     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. ROOD MJ, TEN CATE R, VAN SUIJLEKOM-SMIT LW et al.: Childhood-onset Systemic Lupus Erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 1999; 28: 222-6.
2. LE THI HUANG D, WECHSLER B, PIETTE JC et al.: Clinical manifestations and outcome of childhood systemic lupus erythematosus: a retrospective study of 50 cases. Eur J Intern Med 1993 ; 4: 15-22.
3. YANG LY, CHEN WP, LIN CY: Lupus nephritis in children - a review of 167 patients. Pediatrics 1994; 94: 335-40.
4. BAQI N, MOAZAMI S, SINGH A et al.: Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996; 7: 924-9.
5. BRUNNER HI, GLADMAN DD, IBNEZ D et al.: Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008; 58: 556-62.
6. NWOBI, ABITBOL CL, CHANDAR J, SEEHERUNVONG W, ZILLERUELO G: Rituximab therapy for juvenile-onset systemic lupus erythematosus. Pediatr Nephrol 2008; 23: 413-9.
7. WILLEMS M, HADDAD E, NIAUDET P et al.: Rituximab therapy for childhood-onset systemic lupus erythematosus. J Pediatr 2006; 148: 623-7.
8. PODOLSKAYA A, STADERMANN M, PILLKINGTON C, MARKX SD, TULLUS K: B-Cell depletion therapy for 19 patients with refractory systemic lupus erythematosus. Arch Dis Child 2007 (Epub ahead)
9. RICHER O, ULINSKI T, LEMELLE I et al.: Abdominal manifestations in childhood-onset systemic lupus erythematosus. Ann Rheum Dis 2007; 66: 174-8.
10. BERTSIAS G , IOANNIDIS JP A, BOLETIS J , BOMBARDIERI S , CERVERA R , DOSTAL C: EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2008; 2: 195-205.